Sign inJoin waitlistJoin the waitlist

AB

Alberto Bessudo

Physician · Integrated Oncology Network

Credentials: · · ·

History

Integrated Oncology Network
Present

Hematology and Medical Oncology
University of California (San Diego) Medical Center
1992–1995
Internal Medicine
Barnes-Jewish Hospital
1991–1992
University of Wisconsin School of Medicine and Public Health
1990–1991
National Autonomous University of Mexico
1985–1989

Research

Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study
Journal of Clinical Oncology · 2008 · 247 citations
Denosumab for treatment of hypercalcemia of malignancy
The Journal of Clinical Endocrinology & Metabolism · 2014 · 102 citations
CHAMPION-1: a phase 1/2 study of once-weekly carfilzomib and dexamethasone for relapsed or refractory multiple myeloma
Blood · 2016 · 89 citations

JB
James Berenson
9 papers
RB
Ralph Boccia
6 papers
Robert Vescio
4 papers
SE
Shahrooz Eshaghian
4 papers
Sunil Sharma
4 papers
YN
Youram Nassir
4 papers
JN
John Nemunaitis
3 papers
Lee Rosen
3 papers
Thomas Kipps
3 papers
WH
Wael Harb
3 papers
Alexa Cohen
2 papers · 1 as a resident
AF
Andres Forero-Torres
2 papers

Clinical trials

A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation
Principal investigator · Active not recruiting · Phase 1
HUYABIO International, LLC.
2022–2026
Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors
Principal investigator · Completed · Phase 1
Bio-Cancer Treatment International Limited
2014–2019
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Site PI · Recruiting · Phase 2
GlaxoSmithKline
2021–2026
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
Site PI · Recruiting · Phase 1
Oncotherapeutics
2017–2027